Latest Breaking News On - Completed patient - Page 1 : comparemela.com

ALS Phase 2b PARADIGM Trial Completed Patient EnrollmentTopline results expected in Q-4 2023Cash runway beyond topline clinical study readouts, into Q-2 2024CAMBRIDGE, Mass., Aug. 16, 2023. -Today at 09:01 am- MarketScreener

United kingdomNeurosense therapeutics ltdPrnewswire neurosense therapeutics ltdExchange commissionCompleted patientSense therapeuticsAmyotrophic lateral sclerosisScientific agreementTrial underBiomarker studyBiomarkers summitMonths ended juneInterim unaudited statementsCash flowsNeurosense therapeuticAnnual report